Long-Term Treatment Retention with Topiramate
- 作者C. L. P. Deckers; W. O. Renier
- 卷第42卷
- 期第2期
- 印刷ISSN1528-1167
- 文件大小30.87KB
- 发表时间2001
- DOI10.1111/j.1528-1167.2001.29300-5.x
- 页码288-291
Drug discrimination training during chronic drug treatment affects the development of tolerance.Caul, William F.; Burgin, Kelli L.; Barrett, Robert J. · Behavioral Neuroscience · 1989
Development of Tolerance During Chronic Treatment of Kindled Rats With the Novel Antiepileptic Drug Levetiracetam2000
YFa, a chimeric opioid peptide, induces kappa-specific antinociception with no tolerance development during 6 days of chronic treatmentIshwar Dutt Vats; Karamjit Singh Dolt; Krishan Kumar; Jayashree Karar; Mahendra Nath; Anita Mohan; M. A. Qadar Pasha; Santosh Pasha · 2008
Melatonin secretion during fluvoxamine treatment in medicated chronic schizophrenic patients: Evidence for the development of tolerance to selective serotonin re-uptake inhibitorHenry Silver; Igor Barash; Natan Odnopozov; Najib Jahjah; Alex Mizruhin · 1996
Contribution of the renin-angiotensin-aldosterone system to development of tolerance and fluid retention in chronic congestive heart failure during prazosin treatmentGünter A.J. Riegger; Wilma Haeske; Christine Kraus; Eckhard P. Kromer; Kurt Kochsiek · 1987